Mainz Biomed Bv Stock Target Price
| MYNZ Stock | USD 0.57 0.01 1.79% |
Mainz Biomed BV fundamentals help investors to digest information that contributes to Mainz Biomed's financial success or failures. It also enables traders to predict the movement of Mainz Stock. The fundamental analysis module provides a way to measure Mainz Biomed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mainz Biomed stock.
Mainz | Target Price |
Mainz Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mainz Biomed's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mainz Biomed could also be used in its relative valuation, which is a method of valuing Mainz Biomed by comparing valuation metrics of similar companies.Mainz Biomed is currently under evaluation in target price category among related companies.
Mainz Fundamentals
| Return On Equity | -3.03 | ||||
| Return On Asset | -0.93 | ||||
| Operating Margin | (30.69) % | ||||
| Current Valuation | 12.86 M | ||||
| Shares Outstanding | 21.89 M | ||||
| Shares Owned By Insiders | 21.63 % | ||||
| Shares Owned By Institutions | 0.67 % | ||||
| Number Of Shares Shorted | 300.86 K | ||||
| Price To Book | 6.53 X | ||||
| Price To Sales | 23.71 X | ||||
| Revenue | 895.48 K | ||||
| Gross Profit | 177.62 K | ||||
| EBITDA | (24.67 M) | ||||
| Net Income | (26.3 M) | ||||
| Cash And Equivalents | 26.01 M | ||||
| Cash Per Share | 1.80 X | ||||
| Total Debt | 7.42 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 10.83 X | ||||
| Book Value Per Share | 0.15 X | ||||
| Cash Flow From Operations | (21.94 M) | ||||
| Short Ratio | 1.73 X | ||||
| Earnings Per Share | (1.62) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 65 | ||||
| Beta | 0.28 | ||||
| Market Capitalization | 12.51 M | ||||
| Total Asset | 15.41 M | ||||
| Retained Earnings | (69.33 M) | ||||
| Working Capital | (257.15 K) | ||||
| Net Asset | 15.41 M |
About Mainz Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mainz Biomed BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mainz Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mainz Biomed BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mainz Biomed BV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mainz Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mainz Biomed Bv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mainz Biomed Bv Stock:Check out Mainz Biomed Piotroski F Score and Mainz Biomed Altman Z Score analysis. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Mainz Stock analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Mainz Biomed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mainz Biomed. If investors know Mainz will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mainz Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.62) | Revenue Per Share 0.055 | Quarterly Revenue Growth 0.111 | Return On Assets (0.93) | Return On Equity (3.03) |
The market value of Mainz Biomed BV is measured differently than its book value, which is the value of Mainz that is recorded on the company's balance sheet. Investors also form their own opinion of Mainz Biomed's value that differs from its market value or its book value, called intrinsic value, which is Mainz Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mainz Biomed's market value can be influenced by many factors that don't directly affect Mainz Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mainz Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mainz Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mainz Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.